Page 50 - Dukungan BPOM Dalam Vaksinasi Massal Vaksin Inavac

Judul : COVID-19 Vaccine Circular Permit Will Be Regular In Indonesia When The
Pandemic Turns Endemic
Nama Media : voi.id
Tanggal : 30/05/2023
Halaman/URL : https://voi.id/en/news/283435
Tipe Media : Media Online

The Food and Drug
Supervisory Agency
(BPOM) has increased the
provisions for emergency
use authorization (EU) or
emergency use permit to
become a regular
distribution permit for the
COVID-19 vaccine. The
transition when the health
emergency status in
Indonesia is declared
over.

"This provision is in order
to guarantee protection to
the public in the long term," said Head of BPOM Penny K Lukito while attending the Mass
Vaccination agenda at PT Biotis Pharmaceuticals Indonesia, Gunung Sindur, Bogor Regency, West
Java, Tuesday, May 30, was confiscated by Antara.

Although the vaccine currently in circulation is still EUA, Penny ensures that all products currently in
circulation meet the safety, quality and effectiveness aspects monitored by BPOM and producers on a
regular basis. Including the effectiveness of the vaccine that has been passed through a relatively long
series of clinical trials.

Every technology or platform developed by the COVID-19 vaccine manufacturer has only recently
obtained an emergency use permit due to a pandemic that requires vaccine protection for the public.

As a form of caution from the relevant authorities, BPOM conducts regular supervision every 3 months
to ensure the safety, quality, and effectiveness of vaccines in the beneficiary body.

Producers also involve researchers and experts to participate in supervising side effects that may arise